reference/6734370

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/6734370

Outgoing Links

Predicate	Object
contentType	Journal Article
endingPage	498
issn	1355-008X 1559-0100
issueIdentifier	3
pageRange	489-498
publicationName	Endocrine
startingPage	489
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_a02828554408db63649fffa5fcb7a6ac http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_c7d92db6542fcc029147e8a2354f575f http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_2ab29a25c8e424ff21d9207d0b442842 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_b7e34333473fc0450e0a18362f2b7360 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_573fc6faaf049770f7f6f2c48cbf3e9c http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_d89b99c13d61660f82096e1df60bdec0
bibliographicCitation	Penna GC, Pestana A, Cameselle JM, Momesso D, de Andrade FA, Vidal APA, Araujo Junior ML, Melo M, Fernandes PV, Corbo R, Vaisman M, Sobrinho-Simões M, Soares P, Vaisman F. TERTp mutation is associated with a shorter progression free survival in patients with aggressive histology subtypes of follicular-cell derived thyroid carcinoma. Endocrine. 2018 Sep;61(3):489–98. doi: 10.1007/s12020-018-1642-0. PMID: 29948935.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6ec169adc3e080d59313790bf7beae26 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-6835-7108 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5da5d892793f1816c88aeee211eb8eaf http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_726af03885206dd3d710416adeac9d0a http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_140e2f5229a81f851816d845f27ddc6c http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e48efb9350eb36f2221872d6b0cf3082 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-8365-1380 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_bc5ef812d44d511b67f1b33b12a6526f http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9c9cb03a62a22aea79a5148145c36686 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c9ee207338a903e080303d5c930b1592 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_565afc73c13f10a716e74d5a432220d5 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f21304b0d74383dd7b774ff6ec7d7107 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_199feae4e095d08052e9d675ecbed078 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ed97f92ee59b12e2d4de9274d4e83f6a http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_92cdb1941bfb07b2f08448936caef926
date	2018-06-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://doi.org/10.1007/s12020-018-1642-0 https://pubmed.ncbi.nlm.nih.gov/29948935
isPartOf	http://rdf.ncbi.nlm.nih.gov/pubchem/journal/20589 https://portal.issn.org/resource/ISSN/1355-008X https://portal.issn.org/resource/ISSN/1559-0100
language	English
source	https://scigraph.springernature.com/ https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/
title	TERTp mutation is associated with a shorter progression free survival in patients with aggressive histology subtypes of follicular-cell derived thyroid carcinoma
discusses	http://id.nlm.nih.gov/mesh/M0273402 http://id.nlm.nih.gov/mesh/M0028508
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6404 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7156 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_1c50845b337a3c11fa194521642a3ec8 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8603 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_606d6234a2cf2e2d52b0ade7ed869ca5 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID10168 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6655 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8382 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9419

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID7015

Total number of triples: 53.